Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robbert J de Winter

Showing results (391-400 of 467) with videos related to

Pageof 47
Sort By:
International Journal of Cardiology. Heart & Vasculature|June 5, 2023
Post-spastic flow recovery time to document vasospasm induced ischemia during acetylcholine provocation testingRutger G T Feenstra, Janneke Woudstra, Isa Bijloo, et al.
Circulation|May 20, 2021
Ten-Year All-Cause Death According to Completeness of Revascularization in Patients With Three-Vessel Disease or Left Main Coronary Artery Disease: Insights From the SYNTAX Extended Survival StudyKuniaki Takahashi, Patrick W Serruys, Chao Gao, et al.
Thrombosis and Haemostasis|November 8, 2005
Pre-procedural levels of erythrocyte sedimentation rate (ESR) and risk of clinical restenosis in patients with percutaneous coronary intervention and coronary stent placementJamal S Rana, Pascalle S Monraats, Aeilko H Zwinderman, et al.
Heart Rhythm|January 19, 2021
Identification of patients at risk of sudden cardiac death in congenital heart disease: The PRospEctiVE study on implaNTable cardIOverter defibrillator therapy and suddeN cardiac death in Adults with Congenital Heart Disease (PREVENTION-ACHD)Jim T Vehmeijer, Zeliha Koyak, Jan M Leerink, et al.
JACC. Cardiovascular Interventions|January 2, 2022
10-Year All-Cause Mortality Following Percutaneous or Surgical Revascularization in Patients With Heavy CalcificationHideyuki Kawashima, Patrick W Serruys, Hironori Hara, et al.
International Journal of Cardiology|August 5, 2020
Efficacy and safety of one-month DAPT followed by 23-month ticagrelor monotherapy in patients undergoing proximal LAD stenting: Insights from the GLOBAL LEADERS trialKuniaki Takahashi, Rutao Wang, Hideyuki Kawashima, et al.
The American Journal of Cardiology|October 22, 2023
Outcomes After Complex PCI With COMBO Stent Implantation: Insights from a Real-World Pooled DatasetAlessandro Spirito, Jeremy Nussbaum, Samantha Sartori, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 23, 2018
Complete two-year follow-up with formal non-inferiority testing on primary outcomes of the AIDA trial comparing the Absorb bioresorbable scaffold with the XIENCE drug-eluting metallic stent in routine PCIRuben Yannick G Tijssen, Robin P Kraak, Sjoerd H Hofma, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 31, 2013
Six-month and one-year clinical outcomes after placement of a dedicated coronary bifurcation stent: a patient-level pooled analysis of eight registry studiesMaik J Grundeken, Solomon Asgedom, Peter Damman, et al.
Atherosclerosis|July 19, 2011
Final results of the HEALING IIB trial to evaluate a bio-engineered CD34 antibody coated stent (Genous™Stent) designed to promote vascular healing by capture of circulating endothelial progenitor cells in CAD patientsWijnand K den Dekker, Jaco H Houtgraaf, Yoshinobu Onuma, et al.
Pageof 47

Showing results (391-400 of 467) with videos related to

Sort By:
Pageof 47
International Journal of Cardiology. Heart & Vasculature|June 5, 2023
Post-spastic flow recovery time to document vasospasm induced ischemia during acetylcholine provocation testingRutger G T Feenstra, Janneke Woudstra, Isa Bijloo, et al.
Circulation|May 20, 2021
Ten-Year All-Cause Death According to Completeness of Revascularization in Patients With Three-Vessel Disease or Left Main Coronary Artery Disease: Insights From the SYNTAX Extended Survival StudyKuniaki Takahashi, Patrick W Serruys, Chao Gao, et al.
Thrombosis and Haemostasis|November 8, 2005
Pre-procedural levels of erythrocyte sedimentation rate (ESR) and risk of clinical restenosis in patients with percutaneous coronary intervention and coronary stent placementJamal S Rana, Pascalle S Monraats, Aeilko H Zwinderman, et al.
Heart Rhythm|January 19, 2021
Identification of patients at risk of sudden cardiac death in congenital heart disease: The PRospEctiVE study on implaNTable cardIOverter defibrillator therapy and suddeN cardiac death in Adults with Congenital Heart Disease (PREVENTION-ACHD)Jim T Vehmeijer, Zeliha Koyak, Jan M Leerink, et al.
JACC. Cardiovascular Interventions|January 2, 2022
10-Year All-Cause Mortality Following Percutaneous or Surgical Revascularization in Patients With Heavy CalcificationHideyuki Kawashima, Patrick W Serruys, Hironori Hara, et al.
International Journal of Cardiology|August 5, 2020
Efficacy and safety of one-month DAPT followed by 23-month ticagrelor monotherapy in patients undergoing proximal LAD stenting: Insights from the GLOBAL LEADERS trialKuniaki Takahashi, Rutao Wang, Hideyuki Kawashima, et al.
The American Journal of Cardiology|October 22, 2023
Outcomes After Complex PCI With COMBO Stent Implantation: Insights from a Real-World Pooled DatasetAlessandro Spirito, Jeremy Nussbaum, Samantha Sartori, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 23, 2018
Complete two-year follow-up with formal non-inferiority testing on primary outcomes of the AIDA trial comparing the Absorb bioresorbable scaffold with the XIENCE drug-eluting metallic stent in routine PCIRuben Yannick G Tijssen, Robin P Kraak, Sjoerd H Hofma, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 31, 2013
Six-month and one-year clinical outcomes after placement of a dedicated coronary bifurcation stent: a patient-level pooled analysis of eight registry studiesMaik J Grundeken, Solomon Asgedom, Peter Damman, et al.
Atherosclerosis|July 19, 2011
Final results of the HEALING IIB trial to evaluate a bio-engineered CD34 antibody coated stent (Genous™Stent) designed to promote vascular healing by capture of circulating endothelial progenitor cells in CAD patientsWijnand K den Dekker, Jaco H Houtgraaf, Yoshinobu Onuma, et al.
Pageof 47